Beth Boyer, MPH, is a Policy Research Associate for Biomedical Innovation at the Duke-Margolis Institute for Health Policy, where she primarily leads a portfolio of work focused on drug repurposing and policies that can advance repurposing efforts. While focused largely on US health policy in her current role, Beth has a background in global health and access to medicines and brings this perspective into her work at Duke-Margolis. Previously, she was a Senior Associate at Global Health Strategies, supporting strategic policy and advocacy communications for clients. She also was a former Researcher at the Access to Medicine Foundation, based in Amsterdam, Netherlands. Beth holds a Master of Public Health from Boston University and a Bachelor of Science in Biology from Messiah University.

.